C07C 217/56
With amino groups linked to the six-membered aromatic ring, or to the
Official title: with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
C07C217/56 (With amino groups linked to the six-membered aromatic ring, or to the) appears on 687 US grants and 597 published applications in this corpus.
Search patents in C07C- Granted patents
- 687
- Published applications
- 597
- Assignees
- 416
- Inventors
- 2,019
- Latest grant
- 28 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 4 | 0 |
| 1978 | 2 | 0 |
| 1979 | 4 | 0 |
| 1980 | 5 | 0 |
| 1981 | 2 | 0 |
| 1982 | 3 | 0 |
| 1983 | 3 | 0 |
| 1984 | 3 | 0 |
| 1985 | 6 | 0 |
| 1986 | 3 | 0 |
| 1987 | 3 | 0 |
| 1988 | 8 | 0 |
| 1989 | 8 | 0 |
| 1990 | 8 | 0 |
| 1991 | 16 | 0 |
| 1992 | 10 | 0 |
| 1993 | 23 | 0 |
| 1994 | 12 | 0 |
| 1995 | 23 | 0 |
| 1996 | 17 | 0 |
| 1997 | 24 | 0 |
| 1998 | 20 | 0 |
| 1999 | 13 | 0 |
| 2000 | 18 | 0 |
| 2001 | 17 | 4 |
| 2002 | 27 | 24 |
| 2003 | 14 | 36 |
| 2004 | 32 | 33 |
| 2005 | 16 | 20 |
| 2006 | 12 | 26 |
| 2007 | 17 | 16 |
| 2008 | 15 | 20 |
| 2009 | 11 | 28 |
| 2010 | 15 | 23 |
| 2011 | 15 | 19 |
| 2012 | 18 | 22 |
| 2013 | 16 | 25 |
| 2014 | 22 | 28 |
| 2015 | 25 | 32 |
| 2016 | 25 | 34 |
| 2017 | 18 | 24 |
| 2018 | 23 | 28 |
| 2019 | 17 | 14 |
| 2020 | 19 | 20 |
| 2021 | 12 | 30 |
| 2022 | 19 | 18 |
| 2023 | 10 | 22 |
| 2024 | 16 | 23 |
| 2025 | 9 | 20 |
| 2026 | 7 | 8 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- 5-methoxymethyl and 5-hydroxymethyl phenethylamines28 Jul 2026US 12,692,221 B22A Biosciences, Inc.
- Compound for treating Alzheimer's disease16 Jun 2026US 12,655,088 B2East China University of Science and Technology
- Indane-, indene-, azaindane-, and azaindene-amines as activators of serotonin receptors26 May 2026US 12,636,266 B2Rivo Bio, Inc.
- Phenethylamine derivatives, compositions, and methods of use19 May 2026US 12,630,504 B2Cybin IRL Limited
- Compositions and methods of use comprising substances with neural plasticity actions administered at non-psychedelic/psychotomimetic dosages and formulations5 May 2026US 12,616,706 B2Arbormentis LLC
- Substituted alpha-ethyl phenylalkylamines13 Aug 2026US 2026/0232606 A1Alexander Shulgin Research Institute, Inc.
- Compositions and methods of use comprising substances with neural plasticity actions administered at non-psychedelic / psychotomimetic dosages and formulations13 Aug 2026US 2026/0232704 A1Arbormentis LLC
- Catalyst for sp3-carbon-hydrogen-bond primary amination reaction, and method for preparing primary amine compound13 Aug 2026US 2026/0234096 A1West China Second University Hospital, Sichuan University
- Small molecule drugs and related methods for treatment of diseases related to ab42 oligomer formation25 Jun 2026US 2026/0176230 A1Acelot, Inc.
- Substituted phenylalkylamines18 Jun 2026US 2026/0165986 A1Alexander Shulgin Research Institute, Inc.
Most cited
By later US patents
- Sigma receptor ligands and the use thereof150US 6,057,371 AVirginia Commonwealth University · 2000
- Aryloxypropanolamine .beta. 3 adrenergic agonists115US 5,541,204 ABristol-Myers Squibb Company · 1996
- Calcium receptor-active compounds114US 6,211,244 B1NPS Pharmaceuticals, Inc. · 2001
- Diagnosis, evaluation and treatment of coronary artery disease by exercise simulation using closed loop drug delivery of an exercise simulating agent beta agonist104US 5,460,605 AGensia, Inc. · 1995
- 1-phenyl-3-dimethylaminopropane compounds with a pharmacological effects90US 6,248,737 B1Gruenenthal GmbH · 2001